comparemela.com

Latest Breaking News On - கிஸ்ல் லிமிடெட் - Page 1 : comparemela.com

Australia s CSL unable to simultaneously make Novavax, AstraZeneca vaccines

Asia PacificAustralia s CSL unable to simultaneously make Novavax, AstraZeneca vaccines Reuters 3 minute read CSL Ltd (CSL.AX) said on Thursday it does not have the capacity to simultaneously produce AstraZeneca (AZN.L) and Novavax Inc s (NVAX.O) COVID-19 vaccines after a local report said the U.S.-based firm was looking for an Australian manufacturing partner. Australian biotech CSL is already under contract to locally make 50 million doses of the AstraZeneca vaccine, and is currently churning out more than a million doses a week. read more Australia is relying on deliveries from Pfizer (PFE.N) after restricting the use of AstraZeneca s shot in April in people below 50 years due to rare blood-clotting cases. read more

Outlook on the Biologic Therapeutic Drugs Global Market to 2025 - Growing Geriatric Population is Driving the Industry

Share this article Share this article ResearchAndMarkets.com s offering. The current report offers a detailed picture of the biologics market. This report highlights the current and future market potential for biologics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as key market players. This report details market shares for biologics based on product and geography. Based on product, the market is segmented into therapeutic proteins, vaccines and other segments. Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base y

CSL Ltd reaches record demand for seasonal influenza vaccines

CSL Ltd reaches record demand for seasonal influenza vaccines
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.